Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is a progressively debilitating neurodegenerative disease characterized by α-synucleinopathy, which involves all districts of the brain-gut axis, including the central, autonomic and enteric nervous systems. The highly bidirectional communication between the brain and the gut is markedly influenced by the microbiome through integrated immunological, neuroendocrine and neurological processes. The gut microbiota and its relevant metabolites interact with the host via a series of biochemical and functional inputs, thereby affecting host homeostasis and health. Indeed, a dysregulated microbiota-gut-brain axis in PD might lie at the basis of gastrointestinal dysfunctions which predominantly emerge many years prior to the diagnosis, corroborating the theory that the pathological process is spread from the gut to the brain. Toll-like receptors (TLRs) play a crucial role in innate immunity by recognizing conserved motifs primarily found in microorganisms and a dysregulation in their signaling may be implicated in α-synucleinopathy, such as PD. An overstimulation of the innate immune system due to gut dysbiosis and/or small intestinal bacterial overgrowth, together with higher intestinal barrier permeability, may provoke local and systemic inflammation as well as enteric neuroglial activation, ultimately triggering the development of alpha-synuclein pathology. In this review, we provide the current knowledge regarding the relationship between the microbiota-gut–brain axis and TLRs in PD. A better understanding of the dialogue sustained by the microbiota-gut-brain axis and innate immunity via TLR signaling should bring interesting insights in the pathophysiology of PD and provide novel dietary and/or therapeutic measures aimed at shaping the gut microbiota composition, improving the intestinal epithelial barrier function and balancing the innate immune response in PD patients, in order to influence the early phases of the following neurodegenerative cascade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Systemic inflammation induced by intestinal inflammation and barrier disruption is key in gut–brain communication [57,58,59].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [59]
In the citing paper
“Gut dysbiosis and the consequent development of pathogenic populations within the gut microbiota, may contribute to a wide variety of pathologies, even in sites distant from the gut, ranging from bowel inflammation, to neurodegenerative diseases (including Parkinson’s disease) and cancer [43,49,50].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Haddadi, R., Nayebi, A. M., & Brooshghalan, S. E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.020 · Cited by 39
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Cited by
Items 201–300 of 350
Zhang, L., Zhang, Y., Jiang, X., Mao, L., Xia, Y., Fan, Y., Li, N., Jiang, Z., Qin, X., Jiang, Y., et al. (2022) · Toxicology · doi:10.1016/j.tox.2022.153390 · Cited by 14
Impact of Nutrition on the Gut Microbiota: Implications for Parkinson’s Disease
Sobral, J., Empadinhas, N., Esteves, A. R., & Cardoso, S. M. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuae208 · Cited by 13
Muñoz-Rodríguez, D., Bourqqia‐Ramzi, M., Esteban, M. T., Murciano, A., Vián, A., Lombardo‐Hernandez, J., García-Pérez, P., Conejero, F., González, Á. M., Geuna, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713394 · Cited by 14
“From a therapeutic perspective, various approaches for treating the microbiota have been explored, including targeting a broad spectrum of molecular and cellular elements [49], such as manipulating the activity of Toll-like receptors (TLR), since the microbiota produces several TLR ligands related to the development o…”
BackgroundOverview of peripheral and central inflammatory responses and their contribution to neurotoxicity
Filipov, N. M. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.001 · Cited by 14
Nutrition and Gut–Brain Pathways Impacting the Onset of Parkinson’s Disease
Terenzi, D., Muth, A.-K., & Park, S. Q. (2022) · Nutrients · doi:10.3390/nu14142781 · Cited by 12
Liu, F., Xu, X., Wang, Z., & Wu, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.966004 · Cited by 12
“Interestingly, gut microbiota can cause pathological changes in microbiota microenvironments through the microbiota-gut-brain axis, even destroying the activity and function of the central nervous system, and directly resulting in the occurrence of Parkinson’s Disease (PD), Alzheimer’s Disease (AD), and depression (Ca…”
BackgroundYue, M., Chen, T., Chen, W., Wei, J., Liao, B., Zhang, J., Li, F., Hong, D., & Fang, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00702 · Cited by 11
Feed your microbiome and improve sleep, stress resilience, and cognition
Chichlowski, M., Cotter, J., Fawkes, N., & Pandey, N. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00097 · Cited by 12
“With lower levels of the intestinal hormone ghrelin, researchers observed increased Lactobacillaceae and decreased Prevotellaceae in the gut [61].”
BackgroundCXCL1/CXCR2 is involved in white matter injury in neonatal rats via the gut–brain axis
Yang, C., Feng, Z., Deng, H., Dai, L., He, L., Yin, L., & Zhao, J. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00749-1 · Cited by 11
“Studies have also shown that patients with central nervous system disorders, such as Parkinson’s disease, may experience gastrointestinal dysfunction before diagnosis [32].”
BackgroundLi, H., Liu, D., Li, L.-B., Zhang, Y., Dong, H., Rong, H., Zhang, J., Wang, J.-P., Jin, M., Luo, N., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117319 · Cited by 13
Hung, Y.-F., & Hsueh, Y. (2021) · iScience · doi:10.1016/j.isci.2021.102384 · Cited by 14
Wang, Y., Pu, Z., Zhang, Y., Du, Z., Guo, Z., & Bai, Q. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114240 · Cited by 14
Cerantola, S., Faggin, S., Caputi, V., Bosi, A., Banfi, D., Rambaldo, A., Porzionato, A., Liddo, R. D., De, R., Savarino, E. V., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120562 · Cited by 10
Self-citationMechanisms of oral microflora in Parkinson's disease
Wang, B., Zhang, C. M., Shi, C., Zhai, T., Zhu, J., Wei, D., Shen, J., Liu, Z., Jia, K., & Zhao, L. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115200 · Cited by 12
Berger, A. A., Winnick, A. A., Izygon, J. J., Jacob, B. M., Kaye, J. S., Kaye, R. J., Neuchat, E. E., Kaye, A. M., Alpaugh, E. S., Cornett, E. M., et al. (2022) · Health Psychology Research · doi:10.52965/001c.36074 · Cited by 10
The microbiota-gut-brain axis and three common neurological disorders: a mini-review
Mhanna, A., & Alshehabi, Z. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000552 · Cited by 10
“PD is a common progressive neurodegenerative disease with no fully understood etiology([15]), and no healing treatment until today([16]).”
BackgroundInfluentialThe ketogenic diet in Parkinson’s disease: a potential therapeutic strategy
Pokora, B., Pokora, K., Binienda, A., & Fichna, J. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00799-2 · Cited by 9
“…reduction in SCFAs may play a crucial role in the ENS changes and gut dysmotility seen in PD. SCFAs are synthesized from indigestible carbohydrates by bacteria such as Firmicutes , Bacteroidetes , and Bifidobacte - ria [145], as well as Akkermansia, Lactobacillus [142 , 146 ], and Prevotella [147].”
Micro-nanoplastics and Parkinson’s disease: evidence and perspectives
Lin, L., Li, J., Zhu, S., Zhang, Z., Li, Z., Xu, P., & Guo, W. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01272-4 · Cited by 9
The impact of Parkinson’s disease-associated gut microbiota on the transcriptome in Drosophila
Liu, X., Yang, M., Liu, R., Zhou, F., Zhu, H., & Wang, X. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00176-23 · Cited by 9
“At the molecular level, gut microbiota and its relevant metabo lites interact with the host via a series of biochemical and functional pathways, thereby affecting host homeostasis and health (3).”
BackgroundSall, I., Foxall, R. L., Felth, L. C., Maret, S., Rosa, Z., Gaur, A., Calawa, J., Pavlik, N., Whistler, J. L., & Whistler, C. A. (2025) · Gut Microbes · doi:10.1080/19490976.2024.2446423 · Cited by 9
Rotem‐Kohavi, N., Keane, J., Clarke, G. A., Dinan, T. G., Cryan, J. F., McCarthy, F. P., Oberlander, T. F., & O’Mahony, S. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-60159-1_8 · Cited by 9
Habes, Q. L. M., Konstanti, P., Kiers, H. D., Koch, R. M., Stolk, R. F., Belzer, C., Kox, M., & Pickkers, P. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1278 · Cited by 10
Sadaka, Y., Freedman, J., Ashkenazi, S., Vinker, S., Golan‐Cohen, A., Green, I., Israel, A., Eran, A., & Merzon, E. (2021) · Children · doi:10.3390/children8100880 · Cited by 12
“A disruption of the normal microbiome can affect various brain diseases, such as Alzheimer’s disease and Parkinson’s disease, by increasing the neuroinflammatory state [19,20].”
Pawlowski, K. D., David, B. T., & Fessler, R. G. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2022.0264 · Cited by 10
Tsuchida, S., Umemura, H., Iizuka, K., Yamamoto, H., Shimazaki, I., Shikata, E., & Nakayama, T. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04224-3 · Cited by 9
“The microbiome is closely linked to health, and it has become increasingly clear that imbalances in gut bacteria are closely linked with a range of diseases, including insomnia, depression, autism, Parkinson’s disease, atherosclerosis, diabetes, obesity, inflammatory bowel disease, and atopic dermatitis (Hou et al. 20…”
Li, Y.-H., Jiang, Z., Xu, Q., Jin, T., Huang, J., Luan, X., Li, C., Chen, X., Wong, K., Dong, X., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116518 · Cited by 8
Ayoub, M., Chmouni, Y. A., Damaa, N., Eter, A., Medawar, H., Ghadieh, H. E., Bazzi, S. I., Khattar, Z. A., Azar, S. T., & Harb, F. (2025) · Gene · doi:10.1016/j.gene.2025.149469 · Cited by 8
Shukla, S., Saxena, A., Shukla, S. K., & Nazir, A. (2023) · Diagnostics · doi:10.3390/diagnostics13142322 · Cited by 8
“Food ingestion and modulation of nutrients function as cues to modulate the proteins that are primarily expressed in the gut, and these genes in turn change the metabolome which affects neuronal health and neurotransmission [24].”
BackgroundSlowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies
Vijayakumar, D., & Jankovic, J. J. (2022) · CNS Drugs · doi:10.1007/s40263-022-00903-7 · Cited by 9
“It has been proposed that alteration of the gut microbiome leads to microglial activation, which in turn promotes α-synuclein pathology in the ENS and eventually in the brain [10].”
BackgroundGut–Brain Axis: Role of the Gut Microbiome on Human Health
Poojara, L., Acharya, D., Patel, J. K., & Rawal, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_8 · Cited by 9
Xie, Q., Sun, J., Sun, M., Wang, Q., & Wang, M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105936 · Cited by 9
Yan, Y., Zheng, X., Liu, G., Shi, G., Li, C., Chen, H., He, X., Lin, K.-N., Deng, Z., Zhang, H., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109633 · Cited by 7
“23,36,37 Interestingly, in our study, most of the altered gut bacteria induced by chronic hypoxia were anaerobic.”
Domínguez-Pino, M., Mellado, S., Cuesta, C. M., Grillo-Risco, R., Garcia‐García, F., & Pascual, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312534 · Cited by 7
“…is driven by gut dysbiosis and/or small intestinal bacterial overgrowth, coupled with increased intestinal barrier permeability, can result in both localized and systemic inflammation and enteric neuroglial activation, as seen in certain neurodegenerative diseases like Parkinson’s disease [12].”
Ternák, G., Berényi, K., Németh, B., Szenczi, Á., Márovics, G., & Kiss, I. (2022) · Scientific Reports · doi:10.1038/s41598-022-11569-y · Cited by 7
Çelebi, Ö., Taghizadehghalehjoughi, A., Çelebi, D., Mesnage, R., Golokhvast, K. S., Arsene, A. L., Spandidos, D. A., & Tsatsakis, A. M. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13006 · Cited by 7
The Role of Inflammation in Amyloid Diseases
Azevedo, E. P., & Foguel, D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81888 · Cited by 7
Changes of Dopamine and Tyrosine Hydroxylase Levels in the Brain of Germ-free Mice.
Wang, Y., Qiao, H., & Zhang, Y. (2023) · PubMed Central · doi:10.30498/ijb.2022.236732.2798 · Cited by 7
“Moreover, previous studies have found that the microglia interact with various components of the microflora-intestine-brain axis (28, 29).”
BackgroundMa, C., Wen, H., Wenhao, Y., Changqing, L., Li, C., & Zhao, X. (2024) · Brain and Behavior · doi:10.1002/brb3.70169 · Cited by 6
The gut-brain axis: Unveiling the impact of xenobiotics on neurological health and disorders
Koppula, S., Wankhede, N. L., Kyada, A., Ballal, S., Arya, R., Singh, S. K., Gulati, M., Sute, A. P., Sarode, S. N., Polshettiwar, S. P., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111237 · Cited by 6
Soni, D., Jamwal, S., Chawla, R., Singh, S. K., Singh, D., Singh, T. G., Khurana, N., Kanwal, A., Dureja, H., Patil, U. K., et al. (2024) · Food Reviews International · doi:10.1080/87559129.2024.2337766 · Cited by 6
“[23] The second hit is disruption of neuronal connections between gut and brain.”
InfluentialProgress of non‐motor symptoms in early‐onset Parkinson's disease
Zhang, F., Luo, A., Liao, S., Liu, M., Zhang, J., & Xu, Z. (2024) · Ibrain · doi:10.1002/ibra.12180 · Cited by 7
From Gut Microbiomes to Infectious Pathogens: Neurological Disease Game Changers
Muhasina, K. M., Ghosh, P., Nagappan, K., Palaniswamy, D. S., Begum, R., Islam, M. R., Tagde, P., Shaikh, N. K., Farahim, F., & Mondal, T. K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04323-0 · Cited by 6
“In addition, chronic or rapid MAMP exposure aids disease-related processes [35].”
Gut–Brain Inflammation and Disrupted Homeostasis Due to Activation of Mast Cells and Microglia
Katiraei, P., Frye, R. E., & Theoharides, T. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041768 · Cited by 5
Probiotic: A Gut Microbiota-Based Therapeutic Approaches for the Treatment of Parkinson’s Disease
Rout, M., Prusty, S. K., & Kar, D. M. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328332572241219102122 · Cited by 5
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases
Grahl, M. V. C., Hohl, K. S., Smaniotto, T. Â., & Carlini, C. R. (2025) · Molecules · doi:10.3390/molecules30030687 · Cited by 5
“Complete vagotomy in PD patients resulted in a reduction in disease progression compared to partial vagotomy or no vagotomy, reinforcing the involvement of the vagus nerve and gut–brain interactions in PD [72,73].”
Rethinking Parkinson Disease: Exploring Gut-Brain Interactions and the Potential Role of Exercise
Zapanta, K., Schroeder, E. T., & Fisher, B. E. (2022) · Physical Therapy · doi:10.1093/ptj/pzac022 · Cited by 5
Bacterial Peptides and Bacteriocins as Novel Treatment for Prostate Cancer
Ye, K., Ke, Z., Zhang, X., Liang, K., Zhang, Q., & Huang, J. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10544-z · Cited by 6
“As we know the gut microbiota is the largest bacterial community in our body and any changes in their imbalances can, directly and indirectly, affect on incidence and development of cancers (Hursting 2014; Dembiński et al. 2016; Lane et al. 2017; Caputi and Giron 2018).”
BackgroundArvelo, F. A., Sojo, F. J., & Cotte, C. (2021) · Investigación Clínica · doi:10.22209/ic.v62n4a09 · Cited by 5
Breast Cancer and Its Relationship With the Microbiota
(2019) · Case Medical Research · doi:10.31525/ct1-nct03885648 · Cited by 5
Japanese encephalitis virus infection modulates gut microbiota of immunocompetent mice
Ma, X., Ju, L., Zheng, J., Li, Z., & Gao, L. (2025) · Veterinary Microbiology · doi:10.1016/j.vetmic.2025.110779 · Cited by 5
Tekin, B., & Gurbanov, R. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05017-6 · Cited by 4
“Aging-related intestinal barrier impairment is thought to facilitate microbial translocation and endotoxemia, thereby promoting local immune activation and systemic oxidative stress (Forsyth et al. 2011; Caputi and Giron 2018).”
ZHAO, J.-F., JIANG, Y.-R., GUO, T.-L., JIAO, Y.-Q., & WANG, X. (2024) · Biocell · doi:10.32604/biocell.2024.050120 · Cited by 5
“…human tissues and cells, encompassing dendritic cells (DC), macrophages, neutrophils, B cells, and T cells within the immune system; fi brocytes, epithelial cells, and myocardium within the non-immune system; as well as neurons and glial cells in both the peripheral nervous system and CNS [33].”
Hill, L., Popov, J., Figueiredo, M., Caputi, V., Hartung, E. E., Moshkovich, M., & Pai, N. (2021) · Acta Neuropsychiatrica · doi:10.1017/neu.2021.8 · Cited by 4
Self-citationGrčić, A., Varljen, J., Bedoić, E., Kučić, N., Detel, D., & Batičić, L. (2022) · Medicina Fluminensis · doi:10.21860/medflum2022_271148 · Cited by 4
Onaolapo, A. Y., Ojo, F. O., Olofinnade, A. T., Falade, J., Lawal, I. A., & Onaolapo, O. J. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220903114559 · Cited by 5
Exploring the relationship between novel Coronavirus pneumonia and Parkinson’s disease
Xi, X., & Han, L. (2022) · Medicine · doi:10.1097/md.0000000000031813 · Cited by 4
The gut microbiome as a factor in the development of Parkinson's disease
Арамайисовна, Б. Л., Poluektova, E. A., & Poluektov, M. G. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-1-90-96 · Cited by 4
El‐Mansoury, B., Smimih, K., Khiat, A. E., Fatimi, H. E., Aimrane, A., Baz, S. E., Elmourid, A., Saad, F. E.-Z., Ghachi, H. E., Khanouchi, M., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5156-4.ch017 · Cited by 4
Progress of Immunotherapies in Parkinson's Disease
Peng, Y., Kang, X., Yao, S., Zhang, X., Sugimoto, K., Liu, J., Du, M., Lin, L.-Y., Jiang, D., Chen, Q., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70964 · Cited by 3
“TLRs are important receptors in the innate immune system and are widely distributed in various cells and tissues of the human body [81].”
Zhang, Y., Lv, Y., Wang, Y., Fu, W., Shi, X.-Y., Liu, J., Wen, J., Li, X., & Li, B. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107312 · Cited by 3
The Role of the human microbiome in neurodegenerative diseases: A Perspective
Mukherjea, N., Khandelwal, A., Saluja, R., & Kalra, N. (2025) · Current Genetics · doi:10.1007/s00294-025-01319-8 · Cited by 3
“Ghre - lin exerts a protective influence on dopaminergic neurons by decreasing α-syn accumulation and phosphorylation, increasing autophagy, and inhibiting apoptosis (Caputi and Giron et al. 2018).”
Pang, S., Lu, J., Wang, Y., Chao, Y., Zhao, C., Yue, Z., Yang, Q., & Chan, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01281-3 · Cited by 3
“Toll-likereceptor4 Toll-likereceptor4(TLR4),asaprimaryinterfacebetweentheexternalmicrobial environmentandinternalbiologicalfunctions,playsacentralrolein mediatinggene-environmentinteractionsandthedevelopmentofintestinal in fl ammation 6 – 8 .”
Zimmer, C., Hanson, H. E., Garrison, M., Reese, D., Dor, R., Søraker, J. S., Phuong, H. T., Sheldon, E. L., & Martin, L. B. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.033 · Cited by 4
“For Parkinson ’ s and Alzheimer ’ s disease, TLR signalling can influence neural circuits and immune processes in both the gut and the brain as well as communication between the host and its microbiota (Caputi and Giron, 2018; Lin et al., 2019).”
BackgroundKaur, G., Behl, T., Sehgal, A., Singh, S., Sharma, N., Kumar, A., Arora, S., & BUNGAU, S. G. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01811-z · Cited by 3
RetractedSeeing Neurodegeneration in a New Light Using Genetically Encoded Fluorescent Biosensors and iPSCs
Stellon, D., Talbot, J., Hewitt, A. W., King, A. E., & Cook, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021766 · Cited by 4
Glycoconjugate journal special issue on: the glycobiology of Parkinson’s disease
Brockhausen, I., Schutzbach, J. S., Wang, J., Fishwick, B., & Brockhausen, J. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10024-w · Cited by 4
Wang, Y., Zhu, X., He, Y., Lu, W., Wang, Z., & Liu, F. (2025) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05294-1 · Cited by 2
Sain, M., Rani, S., Singh, S., Pothal, P., Yadav, S., Suttee, A., Kumar, A., Kumar, S., Ranawat, P., Singh, G., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05917-6 · Cited by 2
Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases
Farooqui, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-88460-0.00002-3 · Cited by 3
Contribution of neuroinflammation, resolution, and neuroprotection in neurodegenerative diseases
Farooqui, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-88460-0.00010-2 · Cited by 5
Gastrointestinal health and therapeutic carbohydrate restriction
Campbell-McBride, N., Rice, S. M., & Murphy, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821617-0.00001-2 · Cited by 2
Parvathy, J., Sreedevi, A., Sankaranarayanan, P., & Vasu, S. T. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00331-1 · Cited by 2
Cheng, X., Zhang, Z., Dong, W., Lun, Y., & Liu, B. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.220558 · Cited by 2
Yang, B. K., Jiang, T., Li, Y., Liu, Y., Lin, Z., Fang, Y., & Xu, C. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149948 · Cited by 3
Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice
Sato, M., Arakaki, R., Tawara, H., Tsunematsu, T., & Ishimaru, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063239 · Cited by 2
Helicobacter pylori-associated comorbidity
Sarsenbaeva, A. S. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-193-9-38-52 · Cited by 3
CRISPR-Cas Systems in Gut Microbiome of Children with Autism Spectrum Disorders
Zakharevich, N. V., Nikitin, M. S., Kovtun, A. S., Malov, V. O., Averina, O. V., Даниленко, В. Н., & Artamonova, I. I. (2022) · Life · doi:10.3390/life12030367 · Cited by 2
“Recent research in this area shows a link between neurological diseases such as Alzheimer’s [17] and Parkinson’s [18] diseases, and autism spectrum disorder (ASD).”
BackgroundVastrad, B. M., & Vastrad, C. M. (2025) · Genome Instability & Disease · doi:10.1007/s42764-025-00158-8 · Cited by 2
Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease
Narang, A., & Sandhir, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_1 · Cited by 1
The use of ketogenic diet in therapy of drug-resistant epilepsies – current state of knowledge
Jezierzański, M. M., Furgoł, T., & Miciak, M. (2023) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/168678 · Cited by 1
“KD through reduced protein supply, significantly improves the bioavailability of L-DOPA (1–3, 4 dihydroxyphenylaline), an amino acid that can cross the blood-brain barrier [74].”
BackgroundSarkar, A., Patra, R. K., Ghosh, B., & Mallik, A. (2025) · Collnet Journal of Scientometrics and Information Management · doi:10.47974/cjsim-2023-0107 · Cited by 1
Gut microbiota in regulation of neuromuscular coordination
Roy, S., Chakraborty, B., & Choudhury, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33351-4.00024-6 · Cited by 1
Khawaja, T. W., Zhao, L., Siddiq, R., Ahmad, M. U., Burns, C. P., Parker, J. M., Wakefield, M. R., & Fang, Y. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002351 · Cited by 2
Hasegawa, T., Iwai, S., Ikeda, H. O., Miyaoka, D., Sato, N., Fujimoto, K., Wei, X., Kusaka, M., Miyata, M., Numa, S., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.2.27 · Cited by 2
Lian, C., Ding, N., Xu, Z., Liao, J., Pan, L., Lai, W., Yang, L., Wu, S., Guanghua, Z., Zheng, D., et al. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150449 · Cited by 1
The Role of the Gut in Parkinsons Disease
Worku, D. A., & Matt, R. (2019) · European Journal of Experimental Biology · doi:10.36648/2248-9215.9.2.83 · Cited by 1
“potential therapies such as minocycline which exhibits some neuroprotective effects in PD [2,5,11].”
BackgroundInfluentialInbred mouse model of brain development and intestinal microbiota
Oriá, R. B., Pinto, D. V., Dias, R. P., Raposo, R. D. S., Foley, P. L., Malva, J. O., & Guerrant, R. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817988-8.00048-8 · Cited by 1
Gut Microbiome and Diet: Promising Approach for Treatment of Cognitive Impairment
Soni, A., Gupta, P., & Verma, A. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-4530-4_12 · Cited by 1
INTESTINAL MICROBIOME. EPILEPSY AND THE POSSIBILITY OF EXPANDING ALTERNATIVE THERAPIES
Богданова, Н. М., & Кравцова, К. А. (2023) · Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ) · doi:10.18499/1990-472x-2023-24-3-107-121 · Cited by 1
田, 格. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142347 · Cited by 1
Interplay Between Gut-microbiota and Neurodegeneration
Ashique, S., Pal, R., Kumar, S., Verma, B., Kumar, N., Kahwa, I., Farid, A., Mishra, N., Kumar, P., & Taghizadeh‐Hesary, F. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010009 · Cited by 1
Etiology and pathogenesis of ulcerative colitis from the perspective of modern medicine
Zhen, J., & Huang, G. (2019) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v27.i4.245 · Cited by 1
Gut/brain Axis and its Role in Parkinson’s Disease Progression
Myers, K. (2019) · doi:10.31274/cc-20240624-807 · Cited by 1
Abbaszadeh, S. H., Yousefi, M., Arefhosseini, S. R., Mahmoodpoor, A., & Ebrahimi‐Mameghani, M. (2024) · Preprints.org · doi:10.20944/preprints202401.1988.v1 · Cited by 1
Impact of gastric Helicobacter infections on the stomach-brain axis
Bauwens, E. (2019) · Ghent University Academic Bibliography (Ghent University) · Cited by 1
The Role of the Gut-Brain Axis on Neurodegenerative Diseases
Gustafson, H. (2019) · doi:10.31274/cc-20240624-1489
“The dysfunction of microbiota in the gut may actually be enough of a trigger to cause PD development – the trigger does not necessarily need to be an external factor (Caputi and Giron, 2018).”
BackgroundInfluentialEnvironmental toxicant exposure and Parkinson’s disease: LRRK2 and inflammatory processes
Dwyer, Z. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13709
“While many studies have utilized injections of environmental toxicants such as rotenone and paraquat, recent literature has begun to examine how internal alterations to the gut microbiome may lead to PD [177, 178].”
BackgroundInsulin resistance and Parkinson’s disease
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00007-9
Insulin resistance, dementia, and depression
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00008-0
Molecular mechanisms of neurodegeneration in neurodegenerative diseases
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821711-5.00004-8
Metadata
- Authors
- Caputi, V., & Giron, M. C.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Giron, Maria Cecilia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-06-06
- Volume
- 19
- Issue
- 6
- Pages
- 1689
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6032048
- OpenAlex
- W2807153072
- Cited by
- 338
- References
- 140
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 57 · 2021: 69 · 2020: 43 · 2019: 29 · 2018: 8
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Università degli Studi di Padova (PRID Grant 2017, Assegno di Ricerca 2016)
- San Camillo Hospital, Treviso (Italy) (Grant 2015)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, microbiota-gut-brain axis, Toll-like receptors, synucleinopathies, gut dysbiosis, small intestinal bacterial overgrowth, intestinal permeability, innate immunity, neuroinflammation, gastrointestinal dysfunction, gut microbiota metabolites
- MeSH terms
- Gastrointestinal Microbiome, Animals, Anti-Bacterial Agents, Brain, Humans, Immunity, Innate, Parkinson Disease, Probiotics, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.